(Q41647545)

6 October 2017

1 reference

title

Tumor lysis syndrome in small cell carcinoma and other solid tumors (English)

1 reference

6 October 2017

1 reference

1 reference

Kalemkerian GP

1

1 reference

6 October 2017

Darwish B

series ordinal

2

1 reference

6 October 2017

Varterasian ML

series ordinal

3

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

American Journal of Medicine

6 October 2017

published in

1 reference

6 October 2017

volume

103

1 reference

6 October 2017

issue

5

1 reference

6 October 2017

page(s)

363-367

1 reference

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Chemotherapy of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Small-cell carcinoma of the lung: derivation of a prognostic staging system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Tumor lysis syndrome in nonhematopoietic neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Tumor lysis syndrome after tamoxifen flare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Fatal acute tumor lysis syndrome with metastatic breast carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Spontaneous recurrent tumor lysis syndrome in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Tumor lysis syndrome after combination chemotherapy for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Fatal refractory hyperkalemia due to tumor lysis during primary resection for hepatoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Acute tumour lysis syndrome complicating treatment of stage IVS neuroblastoma in infants under six months old

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Acute tumor lysis syndrome with metastatic medulloblastoma: A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Adoptive chemoimmunotherapy using ex vivo activated memory T-cells and cyclophosphamide: tumor lysis syndrome of a metastatic soft tissue sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Acute tumor lysis syndrome with squamous cell carcinoma of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900153-8

10.1016/S0002-9343(97)00153-8

7 January 2021

Identifiers

DOI

1 reference

release_z5ocrq2bvzf6hekifjqd6fpkka

6 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z5ocrq2bvzf6hekifjqd6fpkka

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference